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ABSTRACT
INTRoduCTIoN: Listeria monocytogenes is a cause of listeriosis, which is dangerous especially for the elderly, 
immunocompromised people, and pregnant women. The ability of these pathogens to colonise biotic and 
abiotic surfaces and form biofilm poses a serious threat for hospitalised, catheterised patients.
MATeRIAl ANd MeThodS: The study was conducted on 29 L. monocytogenes strains isolated from clinical 
materials (blood, cerebrospinal fluid, swabs from vagina) and the reference strain L. monocytogenes ATCC 
1911. The ability of the tested strains to form biofilm in 96-well plates and their drug susceptibility (disk 
diffusion method) was determined.
ReSulTS: All strains formed biofilm, but its intensity was correlated with the source of isolation. A strong 
biofilm formed in 72.73% of isolates from cerebrospinal fluid [(A570 0.421–1.3), 75.0 % of blood isolates 
9 (A570 0.389–1.063), and 50.0 % of isolates from vaginal swabs (A570 0.457–0.487)]. The strongest biofilm 
was formed by strains derived from cerebrospinal fluid whereas isolates from vaginal swabs, which strongly 
formed a biofilm, accounted for 50.0% of the studied population (absorbance 0.457–0.487).
It was found that 93.1% (n = 27) of strains were susceptible to all drugs tested. Two strains (6.9%) were 
resistant to cotrimoxazole and one strain (3.45 %) to erythromycin.
CoNCluSIoNS: The diverse ability of clinical L. monocytogenes strains to form biofilm is an important aspect 
in the prophylaxis of catheterised patients.
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INTRoduCTIoN
L. monocytogenes is a Gram-positive, relatively an-
aerobic, widely distributed in nature (water, soil, 
wastewater), bacterium causing listeriosis [1]. The 
most susceptible to listeriosis are: elderly and immu-
nocompromised people as well as pregnant women 
and newborns. L. monocytogenes has the ability to 
cross natural human barriers: the blood-brain, in-
testinal, and placental barrier [2]. L. monocytogenes 
may cause mild infections such as gastroenteritis or 
contribute to more severe infections affecting the 
central nervous system (CNS) [3]. Clinical symptoms 
include fever, nausea and vomiting, diarrhoea, and 
in the case of invasive forms: bacteraemia and men-
ingitis [4]. In recent years, there have been numer-
ous cases of meningitis caused by L. monocytogenes 
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worldwide. The incidence is estimated at 0.05 and 
0.2 cases per 100,000 population [5].
Bacterial biofilms are found on almost every sur-
face in the natural, medical, and industrial environ-
ment. In the hospital environment, bacterial biofilms 
occur, among others, on catheters and implants 
(e.g. heart valves) leading to difficulties in treatment 
and chronic infections [6]. L. monocytogenes colo-
nises and forms biofilm both on biotic and abiotic 
surfaces. The structure of the biofilm increases bac-
terial resistance to antibiotics as well as the immune 
response of the host [7, 8]. In addition, sub-lethal 
doses of antibiotics may increase the formation of 
bacterial biofilm, which hinders the treatment pro-
cess [9, 10]. Microorganisms that form biofilms of-
ten cause infections that are difficult to detect using 
conventional culturing methods [11].
The objective of this study was to assess the abil-
ity of biofilm formation using crystal violet and drug 
susceptibility of  L. monocytogenes  strains isolated 
from clinical materials.
MATeRIAl ANd MeThodS
Material
The material for the study consisted of 29 strains 
of  L. monocytogenes  isolated  from clinical mate-
rials [blood (BL), cerebrospinal fluid (CSF), vaginal 
swab (VS)] and the reference strain  L. monocyto-
genes ATCC 1911. The tested strains are the part of 
collection of Department of Microbiology, L. Rydygi-
er Collegium Medicum in Bydgoszcz of the Nicolaus 
Copernicus University in Toruń.
The species identification of the cultured strains 
was carried out using the MALDI TOF MS apparatus 
(Bruker), according to the manufacturer’s instructions.
Assessment of biofilm formation using crystal 
violet (CV)
Bacteria were grown for 24 hours, and suspen-
sions of 0.5 McFarland scale density in Mueller 
Hinton broth (MHB, Becton Dickinson) were pre-
pared. Then, 20 μl of each suspension was added, 
in triplicate, to 96-well plates containing 180 μl 
of sterile MHB medium.  The negative control was 
200 μl of sterile MHB medium. The positive control 
was the strain Staphylococcus aureus ATCC 35556, 
for which intensive biofilm formation has been prov-
en. The culture plates were incubated for 24 hours 
(37°C) in a humid chamber. Next, the bacterial sus-
pension was removed, and each well was rinsed 
three times with sterile distilled water and air-dried 
(20 minutes, 37°C). Then methanol (200 μl, Avan-
tor) was added to the wells and the plates were 
shaken (400 rpm, 20 minutes, 25°C). The methanol 
was removed and the wells were air-dried. A wa-
ter solution of 0.1% crystal violet (200 μL, Merck) 
was then added and plates were shaken (400 rpm, 
20 minutes, 25°C). Crystal violet was subsequently 
removed, and the plates were rinsed with water to 
obtain colourless washings and allowed to evap-
orate (20 minutes, 37°C). After drying, methanol 
(200 μl) was added to each well and plates were 
shaken (400 rpm, 5 minutes, 25°C). Absorbance was 
measured at 570 nm wavelength (BIO-TEK spectro-
photometer, Synergy HT Multi-detection) using the 
KC4 v3.4 and KC4 Signature program.
Evaluation of drug resistance 
of L. monocytogenes strains
Antibiotic susceptibility assessment was made us-
ing the disk-diffusion method.  Bacteria from 24-
hour Columbia Agar with 5.0% sheep blood plates 
(CAB, bioMérieux) were used to prepare suspensions 
(0.5 McF) in 0.9% saline (Avantor). The suspensions 
of 100 μL were spread on Mueller Hinton Agar with 
the addition of 5.0% equine blood and 20 μg/ml 
β-NAD (MHF, bioMérieux).  Sensitivity of isolates 
to: penicillin (1 μg), ampicillin (2 μg), meropenem 
(10 μg), erythromycin (15 μg), and cotrimoxazole 
(1.25–23.75 μg) were assessed. Antibiograms were 
incubated at 35°C for 20 hours. After the incubation 
period, growth inhibition zones were measured. In-
terpretation of the results was made in accordance 
with the EUCAST v.8.0 recommendations [12].
Statistical analysis
The intensity of biofilm formation (CV method) was 
determined based on the measured absorbance val-
ues.  The studied strains were divided, depending 
on the strength of biofilm formation and metabolic 
activity in the biofilm, into three groups: weak bio-
film (T–2T), medium biofilm (> 2T–4T), and strong 
biofilm (> 4T). The value of T, calculated from the 
formula T = x nc + 3δ, for CV is 0.091.
The arithmetic mean for the absorbance values 
was calculated  for each  L. monocytogenes  strain 
tested.  The obtained results were subjected to 
statistical analysis in the Statistica 12 PL program 
(StatSoft).  ANOVA with the Tukey post-hoc test was 
used to determine significant differences between 
strains in the ability to form biofilm.
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Based on the chi-square test and Fisher’s exact 
test, differences in the frequency of individual drug 
resistance profiles between strains of different origin 
were checked. The correlation between the number 
of antibiotics that the strain was resistant to and 
the intensity of biofilm formation was also assessed. 
Significance was set at p < 0.05.
ReSulTS
Biofilm formation intensity
It was shown that all tested strains formed a biofilm, 
but the intensity of its formation varied.
Among the tested strains, 66.67% (n = 20) were 
characterised by strong biofilm formation ability, 
whereas 33.33% (n = 10) of strains were classi-
fied into the group of medium biofilm formation 
intensity.  There were no strains with weak biofilm 
formation ability. The intensity of biofilm formation 
correlated with the origin of isolates. Strong biofilm 
formation ability was found in eight (72.73%) strains 
from cerebrospinal fluid (absorbance 0.421–1.3), 
nine (75.0%)  blood isolates (absorbance 0.389–
1.063), and three (50.0%) strains from the vagina 
(absorbance 0.457–0.487). The most intense biofilm 
was created by strains derived from cerebrospinal 
fluid (mean absorbance value — 0.616 ± 0.341), 
which was significantly higher than the values es-
tablished for vaginal strains (0.354 ± 0.147) and 
the reference strain (0.357 ± 0.076) (Fig. 2).  The 
weakest biofilm-formers were found among strains 
isolated from the vagina (Fig. 2).
Drug resistance of L. monocytogenes strains 
tested
Among the 29 tested strains, resistance to cotri-
moxazole was demonstrated in two (6.9%) strains, 
one from cerebrospinal fluid and one from vaginal 
smear. Erythromycin resistance was found in one 
(3.45%) isolate from cerebrospinal fluid.
Three drug resistance profiles were distinguished 
(Table 1). Profile I included 27 (93.1%) strains sen-
sitive to all antibiotics tested, of which 12 (100.0%) 
were blood isolates, 10 (90.91%) were strains isolat-
ed from the cerebrospinal fluid, and five (83.33%) 
were isolates from the vaginal smear (Table 1). This 
profile was statistically rare among strains originating 
from vaginal smear. Profile II included one (3.45%) 
strain isolated from the cerebrospinal fluid, which 
was resistant to both erythromycin and cotrimoxaz-
ole. In turn, profile III comprised one (3.45%) strain 
isolated from a vaginal smear, in which resistance to 
cotrimoxazole was confirmed (Tab. 1).
There was no correlation (Guillford scale, correla-
tion coefficient 0.211) between drug susceptibility 
of  L. monocytogenes  strains  and the intensity of 
biofilm formation (Fig. 3). 
dISCuSSIoN
It siniquitousness and the ability to form biofilms 
makes L. monocytogenes a serious pathogen, pos-
ing a threat to a wide range of patients. A particular 
risk group are catheterised patients. Due to its abil-
ity to produce biofilm,  L. monocytogenes  is more 
resistant to antibiotics, host immune system [7, 8], 
biocides, or stress [13, 14]. L. monocytogenes can 
produce biofilms on various surfaces used in med-
icine or industry, such as polystyrene, glass, and 
stainless steel [15, 16].
It was shown that all tested strains of L. monocy-
togenes  formed a biofilm, but the intensity of its 
formation varied. As much as 66.67% (n = 20) of 
strains were characterised by a strong biofilm inten-
sity, while 33.33% (n = 10) were characterised by 
medium intensity. Similar results were obtained by 
Cirkovic et al. (2016) [19], who showed that 66.67% 
(n = 8) of L. monocytogenes were strong biofilm 
formers, 25.0% (n = 3) medium biofilm formers, 
and 8.33% (n = 1) weak biofilm formers.  In con-
trast, Raby et al. (2016) [17] demonstrated medi-
um and strong biofilm formation ability in 60.0% 
(n = 18) and 40.0% (n = 12) of clinical strains, 
respectively. The strong and moderate ability of bio-
film formation of clinical L. monocytogenes strains 
was also revealed by Borges et al. (2011) [18]. They 
confirmed that 68.0% of strains were characterised 
by medium intensity of biofilm formation whereas 
only 35.0% formed strong biofilm.  In turn, Barbosa 
et al. (2013) [20] found that 70.3% of (n = 83) 
L. monocytogenes clinical strains  formed a weak 
biofilm, and only 3.4% (n = 4) were strong biofilm 
formers [20]. Similar results were obtained by Doi-
jad et al. (2015) [21], who showed that as much as 
65.63% (n = 21) were characterised by low intensity 
of biofilm formation and 34.38% (n = 11) by medi-
um biofilm intensity [21].
It was shown that strains isolated from cere-
brospinal fluid formed biofilm the most intensive-
ly (average absorbance value — 0.616).  On the 
other hand, the weakest biofilm formers were iso-
lated from vaginal swabs (mean absorbance val-
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FiGurE 1. a. The intensity of biofilm formation among L. monocytogenes strains isolated from blood; b. Intensity of biofilm formation 
among L. monocytogenes strains isolated from cerebrospinal fluid; c. Intensity of biofilm formation among L. monocytogenes strains iso-
lated from vaginal swabs; (a, b, c, d 3 values marked with different letters differ statistically significantly, p ≤ 0.05)
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ue — 0.354).  There are no data on the intensity 
of biofilm formation of L. monocytogenes isolated 
from different clinical materials. The study of Raby 
et al. (2016) [17] showed that strains of L. monocy-
togenes isolated from food produced a significantly 
stronger biofilm (p ≤ 0.05) than the strains isolated 
from clinical material.   Also, Doijad et al. (2015) 
[21] showed that the intensity of biofilm forma-
tion is correlated with the isolation source of the 
strain. Among animal isolates 34.38% (n = 11) were 
characterised by moderate biofilm formation inten-
sity whereas 65.63% (n = 21) formed weak bio-
film [21]. Among human isolates 55.56% (n = 10) 
showed a weak biofilm formation rate, and 44.44% 
(n = 8) were classified as biofilm-forming strains. In 
contrast, among strains isolated from meat, only 
14.29% (n = 2) were classified into the strains with 
moderate biofilm intensity and as much as 85.71% 
(n = 12) were strains with low intensity. No strain 
isolated from these sources showed strong biofilm 
formation. On the other hand, among strains iso-
lated from milk and milk products, 26.46% (n = 9) 
showed a strong biofilm formation ability, 17.65% 
(n = 6) of strains were moderate biofilm formers, 
and 55.88% (n = 19) were classified as strains of 
weak biofilm [21].
In our own study it was shown that 93.1% 
(n = 27) of strains were sensitive to all tested antibi-
otics. In two (6.9%) strains cotrimoxazole resistance 
was demonstrated, and in one (3.45%) strain – re-
sistance to erythromycin. All isolates were sensitive 
to penicillin, ampicillin, and meropenem. Also, Raby 
et al. (2016) [17] showed that the majority of clin-
ical strains 83.33% (n = 25) were susceptible to 
the tested antibiotics. However, they found three 
(10.0%) strains and two (6.67%) strains resistant 
to meropenem and penicillin, respectively [17]. The 
study of  Winiarska (2017) [22] also revealed one 
strain resistant to meropenem and additionally three 
(30.0%) erythromycin-resistant strains, whereas Bor-
FiGurE 2. Comparison of mean values of absorbances obtained 
by CV between groups of L. monocytogenes strains (a, b — val-
ues marked with different letters differ significantly between each 
other, p ≤ 0.05)
FiGurE 3. Correlation between the number of antibiotics to 
which the strain is resistant and the intensity of biofilm formation 
by L. monocytogenes
Table 1. Drug resistance profiles among the tested strains
The name of the drug resistance 
profile
Drug resistance profile Number of strains depending on the origin [n, %]
BL CSF VS
I S: P, AM, E, MEM, SXT
R: ---
12 (100.0%)a 10 (90.91%)a 5 (83.33%)b
II S: P, AM, MEM,
R: E, SXT
0a 1 (9.09%)b 0a
III S: P, AM, E, MEM,
R: SXT
0a 0a 1 (16.67%)b
Total [n, %] 12 (100.0%) 11 (100.0%) 6 (100.0%)
a, b — values marked with different letters differ significantly statistically (p < 0.05)
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can et al. (2014) [23] showed resistance to ampicillin 
(7.7%, n = 2), penicillin (7.7%, n = 2), and eryth-
romycin (3.85%, n = 1).  In turn, in the studies of 
Madeo et al. (2015) [24] and Caplan et al. (2014) 
[25] susceptibility to penicillin, meropenem, and 
erythromycin in all clinical isolates of L. monocyto-
genes was reported.
Conclusions
The results of our study show that  L. monocyto-
genes  strains  isolated from clinical materials are 
characterised by a diverse ability to form bio-
film. Therefore, it is recommended to control biofilm 
formation in catheterised patients.
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